Fulgent Genetics (FLGT) Profit After Tax (2015 - 2026)

Fulgent Genetics has disclosed Profit After Tax across 12 years of filings, most recently posting -$24.8 million for Q1 2026.

• Profit After Tax for Q1 2026 came in at -$24.8 million, down 108.64% year-over-year; the trailing twelve-month figure through Mar 2026 was -$74.3 million (down 77.7% YoY), and the FY2025 annual result was -$60.5 million, down 38.09% from the prior year.
• Profit After Tax came in at -$24.8 million for Q1 2026 at Fulgent Genetics, down from -$23.4 million in the prior quarter.
• In the past five years, Profit After Tax ranged from a high of $153.6 million in Q1 2022 to a low of -$134.3 million in Q4 2023.
• The 5-year median for Profit After Tax is -$13.1 million (2023), against an average of -$9.6 million.
• Across the five-year window, Profit After Tax plunged 862.48% in 2023 and jumped 95.39% in 2024, its largest moves.
• Fulgent Genetics' Profit After Tax stood at -$24.1 million in 2022, then plunged by 457.96% to -$134.3 million in 2023, then surged by 95.39% to -$6.2 million in 2024, then slumped by 278.32% to -$23.4 million in 2025, then retreated by 6.01% to -$24.8 million in 2026.
• The last three Profit After Tax figures came in at -$24.8 million (Q1 2026), -$23.4 million (Q4 2025), and -$6.8 million (Q3 2025), per Business Quant data.